Volitionrx (VNRX) Shares Outstanding (2011 - 2026)
Volitionrx's (VNRX) quarterly Shares Outstanding (Entity) came in at $6.3 million in Q4 2025, up 30.89% YoY from $4.8 million in Q4 2024, and up 14.74% on a QoQ basis from $5.5 million in Q3 2025.
Volitionrx (VNRX) Shares Outstanding (2011 - 2026) Analysis & Trends
Volitionrx (VNRX) has 15 years of Shares Outstanding (Entity) data on file, last reported at $6.3 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 30.89% year-over-year to $6.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (up 30.89% YoY) and the FY2025 annual result came in at $6.3 million, up 30.89% from the prior year.
- Shares Outstanding (Entity) improved to $6.3 million in Q4 2025, from $5.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $6.3 million in Q4 2025 to a low of $2.6 million in Q1 2021.
- A 5-year average of $3.8 million and a median of $3.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 1.32% — and 2023, when it surged 45.11%.
- Tracing VNRX's Shares Outstanding (Entity) over 5 years: stood at $2.7 million in 2021, then rose by 7.63% to $2.9 million in 2022, then jumped by 41.51% to $4.1 million in 2023, then advanced by 17.34% to $4.8 million in 2024, then surged by 30.89% to $6.3 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $6.3 million (Q4 2025), $5.5 million (Q3 2025), and $5.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Volitionrx | 1.21 Mn | -1.58 Mn | - | 2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.39 Mn |
| Dec 31, 2025 | 4.39 Mn |
| Sep 30, 2025 | 4.39 Mn |
| Jun 30, 2025 | 4.39 Mn |
| Mar 31, 2025 | 4.39 Mn |
| Dec 31, 2024 | 4.39 Mn |
| Sep 30, 2024 | 4.39 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | 3.56 Mn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 3.01 Mn |
| Dec 31, 2022 | 2.77 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 2.69 Mn |
| Mar 31, 2022 | 2.69 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 2.66 Mn |
| Jun 30, 2021 | 2.65 Mn |